SRH Total Return Fund, Inc. (BIF) Income Statement Analysis

See more : Nanjing Well Pharmaceutical Group Co.,Ltd. (603351.SS) Income Statement Analysis – Financial Results

Complete financial analysis of SRH Total Return Fund, Inc. (BIF) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of SRH Total Return Fund, Inc., a leading company in the Asset Management industry within the Financial Services sector.

You may be interested

SRH Total Return Fund, Inc. (BIF)

Industry: Asset Management

Sector: Financial Services

Website: https://www.boulderfunds.net/bif-fundobjective.php

About SRH Total Return Fund, Inc.

SRH Total Return Fund, Inc. is a closed-ended balanced mutual fund launched and managed by Boulder Investment Advisers, L.L.C. It is co-managed by Stewart West Indies Trading Co Ltd. and Rocky Mountain Advisers, Llc. The fund invests in public equity and fixed income markets across the globe. It seeks to invest in securities of companies operating across diversified industries. The fund primarily invests in dividend paying value stocks of companies across all capitalizations, as well as in fixed income securities issued by companies. It employs both fundamental and quantitative analysis with a bottom-up security picking approach, focusing on such factors as defensible businesses with solid financial positions and strong operating track records to create its portfolio. The fund benchmarks the performance of its portfolio against the S&P 500 Composite Index. SRH Total Return Fund, Inc. was formed on December 7, 1972 and is domiciled in the United States.

Metric	2021	2020	2019	2018	2017
Revenue	276.25M	-1.98M	61.36M	97.79M	251.00M
Cost of Revenue	0.00	0.00	0.00	0.00	0.00
Gross Profit	276.25M	-1.98M	61.36M	97.79M	251.00M
Gross Profit Ratio	100.00%	100.00%	100.00%	100.00%	100.00%
Research & Development	0.00	0.00	0.00	0.00	0.00
General & Administrative	2.67M	2.06M	2.19M	3.18M	3.50M
Selling & Marketing	0.00	0.00	0.00	0.00	0.00
SG&A	2.67M	2.06M	2.19M	3.18M	3.50M
Other Expenses	-375.44K	-94.88K	37.34K	35.56K	37.29K
Operating Expenses	2.30M	1.96M	2.23M	3.21M	3.54M
Cost & Expenses	2.30M	1.96M	2.23M	3.21M	3.54M
Interest Income	33.80K	1.06M	2.77M	2.67M	0.00
Interest Expense	6.12M	439.38K	0.00	138.48K	887.12K
Depreciation & Amortization	236.56K	206.30K	171.86K	161.14K	52.52K
EBITDA	280.07M	-3.50M	59.13M	94.72M	248.35M
EBITDA Ratio	101.38%	177.06%	96.36%	96.86%	98.94%
Operating Income	280.07M	-3.50M	59.13M	94.72M	248.35M
Operating Income Ratio	101.38%	177.06%	96.36%	96.86%	98.94%
Total Other Income/Expenses	-6.12M	-439.38K	0.00	-138.48K	-887.12K
Income Before Tax	273.96M	-3.94M	59.13M	94.58M	247.46M
Income Before Tax Ratio	99.17%	199.29%	96.36%	96.72%	98.59%
Income Tax Expense	0.00	0.00	0.00	0.00	0.00
Net Income	273.96M	-3.94M	59.13M	94.58M	247.46M
Net Income Ratio	99.17%	199.29%	96.36%	96.72%	98.59%
EPS	2.79	-0.04	0.59	0.91	2.32
EPS Diluted	2.79	-0.04	0.59	0.91	2.32
Weighted Avg Shares Out	98.27M	98.27M	100.22M	103.94M	106.66M
Weighted Avg Shares Out (Dil)	98.27M	98.27M	100.22M	103.94M	106.66M